| Literature DB >> 24464223 |
G Tufo1, A W E Jones2, Z Wang1, J Hamelin3, N Tajeddine4, D D Esposti3, C Martel5, C Boursier6, C Gallerne1, C Migdal7, C Lemaire8, G Szabadkai9, A Lemoine3, G Kroemer10, C Brenner1.
Abstract
Intrinsic and acquired chemoresistance are frequent causes of cancer eradication failure. Thus, long-term cis-diaminedichloroplatine(II) (CDDP) or cisplatin treatment is known to promote tumor cell resistance to apoptosis induction via multiple mechanisms involving gene expression modulation of oncogenes, tumor suppressors and blockade of pro-apoptotic mitochondrial membrane permeabilization. Here, we demonstrate that CDDP-resistant non-small lung cancer cells undergo profound remodeling of their endoplasmic reticulum (ER) proteome (>80 proteins identified by proteomics) and exhibit a dramatic overexpression of two protein disulfide isomerases, PDIA4 and PDIA6, without any alteration in ER-cytosol Ca(2+) fluxes. Using pharmacological and genetic inhibition, we show that inactivation of both proteins directly stimulates CDDP-induced cell death by different cellular signaling pathways. PDIA4 inactivation restores a classical mitochondrial apoptosis pathway, while knockdown of PDIA6 favors a non-canonical cell death pathway sharing some necroptosis features. Overexpression of both proteins has also been found in lung adenocarcinoma patients, suggesting a clinical importance of these proteins in chemoresistance.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24464223 PMCID: PMC3978299 DOI: 10.1038/cdd.2013.193
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 15.828